{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:15:36Z","timestamp":1793110536015,"version":"4.5.0"},"reference-count":22,"publisher":"Wiley","issue":"15","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["20180530063"],"award-info":[{"award-number":["20180530063"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Patient\u2010controlled subcutaneous analgesia (PCSA) with sufentanil is an alternative analgesia strategy in patients with stage III\u2010IV cancer; however, its efficacy and safety have not been fully investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From May 10, 2017 to November 10, 2017, 120 patients with stage III\u2010IV cancer suffering from moderate to severe pain were prospectively enrolled from six hospitals and randomized to receive PCSA with morphine (control group) or sufentanil (intervention group). Before the PCSA and on days 1, 3, 7, 14, 28, and 56 after treatment, the numeric rating scale (NRS) and 36\u2010item Short Form health survey (SF\u201036) were completed for each patient and the side effects were also recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      No significant differences (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&gt;\u00a0.05) were observed in the preoperative NRS score and the SF\u201036 parameters between the two groups. Patients in the intervention group achieved better pain relief, as indicated by lower NRS scores at days 14 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.040), 28 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a0.001), and 56 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a0.001) after PCSA device implantation (vs control group). Furthermore, the patients in the intervention group also achieved a better life quality, as indicated by the physical role, general health, social function body pain, and mental health scores. Finally, the patients receiving sufentanil showed lower levels of nausea and somnolence than those in the control group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PCSA with sufentanil achieves better pain control and life quality as well as fewer adverse reactions in stage III\u2010IV cancer patients with pain and may be a promising pain management in these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study was registered at chictr.org.cn with the trial number: ChiCTR\u2010IPR\u201017011280.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cam4.3194","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T21:24:44Z","timestamp":1591305884000},"page":"5345-5352","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Patient\u2010controlled subcutaneous analgesia using sufentainil or morphine in home care treatment in patients with stage III\u2010IV cancer: A multi\u2010center randomized controlled clinical trial"],"prefix":"10.1002","volume":"9","author":[{"given":"Cheng\u2010Fu","family":"Wan","sequence":"first","affiliation":[{"name":"Pain Department of the First Affiliated Hospital China Medical University Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing\u2010Zhu","family":"Meng","sequence":"additional","affiliation":[{"name":"Pain Department of the Central Hospital of Haicheng city Anshan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan\u2010Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Pain Department of the Third People's Hospital of Anshan city Anshan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Qi","sequence":"additional","affiliation":[{"name":"Pain Department of the Central Hospital of Fuxin city Fuxin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang\u2010Liang","family":"Ai","sequence":"additional","affiliation":[{"name":"Pain Department of the Women and Children's Hospital of Dandong city Dandong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sui","sequence":"additional","affiliation":[{"name":"Pain Department of the Central Hospital of Kuandian city Dandong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9915-9673","authenticated-orcid":false,"given":"Tao","family":"Song","sequence":"additional","affiliation":[{"name":"Pain Department of the First Affiliated Hospital China Medical University Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.06.035"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.471"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2003.08.001"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-011-1101-9"},{"issue":"35","key":"e_1_2_11_6_1","first-page":"40","article-title":"Patient\u2010controlled analgesia (PCA) in outpatients with cancer pain. Analysis of 1,692 treatment days","volume":"21","author":"Schiessl C","year":"2007","journal-title":"Schmerz"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/112972980300400204"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-2036-8"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3447-0"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31828f29f8"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049909112448924"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00084-6"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7323581"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2015.0342"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2014.0189"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12238"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079828"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31303"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30825"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep39397"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269216310386280"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/NCC.0000000000000166"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcam4.3194","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.3194","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.3194","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.3194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T22:20:33Z","timestamp":1693347633000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.3194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":22,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1002\/cam4.3194"],"URL":"https:\/\/doi.org\/10.1002\/cam4.3194","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"2019-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}